Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Akela Pharma Inc. AKLPF

"Akela Pharma Inc is engaged in providing contract services comprised of pharmaceutical formulation research and development, pre-clinical, clinical and commercial drug manufacturing, product development and patent litigation support."

GREY:AKLPF - Post Discussion

Akela Pharma Inc. > We are relocating from Austin, TX to Torrey Pines
View:
Post by Biostocks01 on Nov 21, 2012 8:03pm

We are relocating from Austin, TX to Torrey Pines

Oct162012

Contract manufacturer PharmaForm, a subsidiary of Akela Pharma, has announced plans to move from Austin, TX to the San Diego, CA area. The company offers formulation and manufacturing services for numerous dosage forms, including nasal sprays and inhalation powders.

PharmaForm President and CEO Rudy J. Emmelot commented, “We are excited about our move to San Diego and becoming part of the San Diego and California pharmaceutical and biotechnology centers. The Torreyana facility allows PharmaForm to expand beyond its current expertise of formulation development and solubility solutions for the pharmaceutical and biotechnology industries.”

The company’s corporate headquarters will be located at the new site in Torrey Pines, along with R&D, formulation, and manufacturing units.

From BIo...

Ifound this article onthe web and Iwould like to sharewith the shareholders...AkelaPharmahas not issued anystatementabout it.This is unacceptable

Comment by testfreak on Nov 21, 2012 8:07pm
Sold out of this at 0.03 at a loss due to this reason. Lack of news. Good luck here bio. Could turn around  
Comment by Biostocks01 on Nov 21, 2012 8:25pm
thank you testfreak, I wrote tsx and Emmelot to denounce this situation!! Bio
Comment by Biostocks01 on Nov 21, 2012 8:29pm
here is the link of this new...https://www.oindpnews.com/2012/10/pharmaform-moving-to-san-diego/Bio
Comment by Biostocks01 on Nov 21, 2012 8:35pm
Testfreak, if you know of others interested in this company, send an email to them... Bio
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities